Pharmacological Treatments for Cocaine Dependence: Is There Something New?

Author(s): Laurent Karila, Michel Reynaud, Henri-Jean Aubin, Benjamin Rolland, Dewi Guardia, Olivier Cottencin, Amine Benyamina

Journal Name: Current Pharmaceutical Design

Volume 17 , Issue 14 , 2011

Become EABM
Become Reviewer
Call for Editor


Introduction: There is no specific and approved treatment, by regulatory authorities, for cocaine dependence. Therefore, developing new medications for the treatment of this disease continues to be a research priority. Recent advances in neurobiology and brain imaging studies have suggested several promising pharmacological approaches.

Materials and Methods: Literature searches were conducted for the period from January 1990 to February 2011 using PubMed, EMBASE, PsycInfo, the NIDA research monograph index and the reference list of, which are the main electronic sources of ongoing trials.

Results: Recent controlled clinical studies have highlighted some very promising medications, especially glutamatergic (NAcetylcysteine, modafinil, topiramate) and GABAergic (vigabatrin) agents, agonist replacement therapy (sustained-release methylphenidate, d-amphetamine) and dopamine agents (disulfiram). Additionally, immunotherapy is a new and promising pharmacological approach.

Conclusion: Promising pharmacological approaches have emerged for the treatment of cocaine dependence, but larger, randomized, placebo- controlled studies are needed for some medications. Preclinical studies suggest new targets of interest in cocaine dependence. The optimal therapeutic platform is the combination of pharmacotherapies with behavioral therapies.

Keywords: Cocaine, dependence, addiction, pharmacotherapy, vaccine, immunotherapy, clinical trials, N-Acetylcysteine, modafinil, vigabatrin, disulfiram, Aripiprazole, methylphenidate, psychostimulant, multifactorial, paraphernalia, dopamine, serotonin, norepinephrine, endocannabinoid, acetylcholine

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [1359 - 1368]
Pages: 10
DOI: 10.2174/138161211796150873
Price: $65

Article Metrics

PDF: 22